While in the article by Shi et al. (2012), the authors indicate that JAK2 deletion in the liver protects mice against whole-body insulin resistance and glucose intolerance, it concurrently promotes hepatic steatosis but, surprisingly, did not evolve into steatohepatitis. Here, JAK2 is linked to Insulin resistance.